missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ CD59 Monoclonal Antibody (MEM-43), PE, Invitrogen™
Mouse Monoclonal Antibody
343.00 EUR - 1168.00 EUR
Specifications
Antigen | CD59 |
---|---|
Clone | MEM-43 |
Concentration | 0.1mg/mL |
Dilution | Assay-dependent |
Applications | Flow Cytometry |
Product Code | Brand | Quantity | Price | Quantity & Availability | |||||
---|---|---|---|---|---|---|---|---|---|
Product Code | Brand | Quantity | Price | Quantity & Availability | |||||
10680864
|
Invitrogen™
MHCD5904 |
500 μL |
343.00 EUR
Each |
Please sign in to purchase this item. Need a web account? Register with us today! | |||||
10303453
|
Invitrogen™
MHCD59044 |
2 mL |
1168.00 EUR
Each |
Please sign in to purchase this item. Need a web account? Register with us today! | |||||
Description
R-phycoerythrin (PE) is a stable and highly soluble phycobiliprotein which provides maximal absorbance and fluorescence without susceptibility to internal or external fluorescence quenching, thus providing an exceptional quantum yields and molar extinction coefficients.
CD59 (Protectin) is a small (18-20 kDa) GPI-anchored ubiquitously expressed inhibitor of the membrane attack complex (MAC). CD59 is the key regulator that preserves the autologous cells from terminal effector mechanism of the complement cascade. CD59 also associates with C5b-8 complex and counteracts appropriate formation of cytolytic pore within the plasma membrane. Further, CD59 is a low-affinity ligand of human CD2, causes T cell costimulation, and is involved in lymphocyte signal transduction. CD59 is a potent inhibitor of the complement membrane attack complex, whereby it binds complement C8 and/or C9 during the assembly of this complex, thereby inhibiting the incorporation of multiple copies of C9 into the complex, which is necessary for osmolytic pore formation. Mutations in this gene cause CD59 deficiency, a disease involving hemolytic anemia, thrombosis, and cerebral infarction. Multiple alternatively spliced transcript variants of CD59 have been identified.Specifications
CD59 | |
0.1mg/mL | |
Flow Cytometry | |
PE | |
Mouse | |
PBS with 10% sucrose, 4mg/mL BSA and 0.1% sodium azide | |
966 | |
Human CD59 | |
Primary | |
CD59 | |
18 to 20kDa |
MEM-43 | |
Assay-dependent | |
Monoclonal | |
Liquid | |
Human | |
P13987 | |
CD59 | |
IgG2a | |
purified | |
0.1% Sodium azide | |
1 Each |
Analyte Specific Reagent. Analytical and performance characteristics are not established.